Skip to main content | The UK's largest nursing archive

Advanced search

Kathyrn McCall, Bridget Johnston
International Journal of Palliative Nursing, Vol. 13, Iss. 10, 26 Oct 2007, pp 486 - 488

Advances in medical science and technology, combined with the primary goal of medical care to restore or maintain health as far as possible, often result in the transition from active to palliative care being blurred. Treatment choices are limited in advanced disease; but paradoxically, which therapy to choose is becoming an increasingly complex decision (Weissman, 2004). The role of chemotherapy in this phase remains a controversial subject, but data are emerging to show that an increasing number of patients nearing the end of life are receiving chemotherapy (Matsuyama et al, 2006), and there is a mounting body of evidence for its use in symptom palliation (Cullen, 2003; Bowcock et al, 2004; Davis, 2005). Therefore, the traditional view that medical oncology and palliative care are two distinct disciplines may need to
be modified.

Return to article listing Request Permissions

To view this article

Existing users sign in Personal subscription 24 Hour access Pay per article